Biorasi CRO Solutions Expo: Finding The Right Partner For Early-Stage Oncology Trials

Projects that combine both drug and device components demand thoughtful, upfront strategic planning to ensure a seamless start. From navigating combination-product pathways to aligning clinical, technical, and regulatory requirements, early decisions can make or break program momentum. With complex approval routes and evolving compliance expectations, regulatory considerations are not just important — they are the foundation of successful early-stage oncology trial execution.